TENS Unit denials in California external review
In the California DMHC record, independent physician reviewers decided 22 published external-review cases involving TENS Unitand overturned the plan’s denial in 22.7%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.
Conditions behind TENS Unit denials
| Category | Decisions | Overturned |
|---|---|---|
| Back Pain | 4 | 0% |
What the insurer actually argued
| Reason given | Decisions | Overturned |
|---|---|---|
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 14 | 28.6% |
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 8 | 12.5% |
What the reviewers wrote
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for a transcutaneous electrical nerve stimulation (TENS) device. In this case, the patient has been diagnosed with systemic lupus erythematosus and is experiencing chronic pain in his neck, lower back, and legs. The record establishes that the patient has utilized physical, chiropractic, and pharmacological therapy without complete remission of symptoms. Overall, TENS is an appropriate evidence-based treatment option in addition to other conservative therapies in this clinical setting. As such, the requested TENS device is necessary to prevent significant disability and alleviate severe pain through the treatment of a disease. In addition, the TENS device is necessary to attain, maintain, or regain functional capacity.
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for a transcutaneous electrical nerve stimulation (TENS) unit. The American Physical Therapy Association defines TENS as a noninvasive and safe application of electrical stimulation to the skin for pain control. One group of authors performed a systematic review of several recent randomized controlled trials regarding interventional treatments for postherpetic neuralgia (PHN). Several trials found that the use of TENS resulted in significant reduction in pain scores in the short- and long-term. This patient presents with a diagnosis of PHN. She has tried and failed conservative treatment. The medical literature supports the use of TENS for patients with PHN.
Where the denial was upheld
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for a transcutaneous electrical nerve stimulation (TENS) device and electrodes for treatment of the enrollee’s low back pain with radiation to right anterior thigh. Findings: The physician reviewer found that while TENS may reflect the longstanding accepted standard of care within many medical communities, the results of clinical trials are inconclusive regarding improved health outcomes. Overall, the published studies do not provide information on the stimulation parameters which are most likely to provide optimum pain relief, nor do they answer questions about long-term effectiveness. Several published evidence based assessments of TENS have found that evidence is lacking concerning effectiveness.
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for sacral nerve stimulation for treatment of the enrollee’s anal pain and sphincterotomy. Findings: Two physician reviewers found that within the field of colorectal surgery, the primary indication for sacral nerve stimulation is fecal incontinence. There is a lack of significant data supporting the use of sacral nerve stimulation for levator syndrome, anal pain or chronic pelvic pain. A systematic review on nerve stimulation for chronic pelvic pain and bladder pain syndrome concluded that there were no reported data for sacral nerve stimulation. Additionally, there is a paucity of literature reporting variable success of posterior tibial nerve stimulation in improving pain, urinary symptoms and quality of life for both chronic pelvic pain and bladder pain syndrome.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.
These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving TENS Unit, then check the rights and deadlines that apply to your plan.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY